» Articles » PMID: 35801360

Tertiary Lymphoid Structures in Lung Adenocarcinoma: Characteristics and Related Factors

Overview
Journal Cancer Med
Specialty Oncology
Date 2022 Jul 8
PMID 35801360
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Tertiary lymphoid structures (TLSs) are found in a variety of malignancies and affect the growth of tumors, but few studies have addressed their role in lung adenocarcinoma (LAC). We aimed to evaluate clinical features associated with TLSs in patients with LAC.

Methods And Materials: A collection of resected pulmonary nodules in patients with LAC was retrospectively analyzed. TLSs were quantified by their number per square millimeter tumor area (density) and by the degree of lymphocyte aggregation (maturity) in each case. The correlation between TLS density and maturity and clinical features was calculated.

Results: A total of 243 patients were selected, of whom 219 exhibited TLSs. The occurrence of TLSs was correlated with computed tomography (CT) features as follows: pure ground-glass nodules (pGGNs) (n = 43) was associated with a lower occurrence rate than part-solid nodules (PSNs) (n = 112) and solid nodules (SNs) were (n = 88) (p = 0.037). TLS density was correlated with age and CT features. Poisson regression showed higher TLS density in PSNs and SNs than in pGGNs (incidence rate ratio [IRR]: 3.137; 95% confidence interval [CI]: 1.35-7.27; p = 0.008 and IRR: 2.44; 95% CI: 1.02-5.85; p = 0.046, respectively). In addition, TLS density was higher in patients aged under 60 years than in those aged over 60 years (IRR: 0.605; 95% CI: 0.4-0.92; p = 0.018). The maturity of TLSs was higher in patients with higher tumor stages (p = 0.026).

Conclusions: We demonstrated distinct profiles of TLSs in early LAC and their correlations with CT features, age, and tumor stages, which could help understand tumor progression and management.

Citing Articles

Simultaneous immunomodulation and epithelial-to-mesenchymal transition drives lung adenocarcinoma progression.

Kim J, Ravichandran H, Yoffe L, Bhinder B, Finos K, Singh A bioRxiv. 2025; .

PMID: 40027685 PMC: 11870609. DOI: 10.1101/2025.02.19.637138.


Determining the status of tertiary lymphoid structures in invasive pulmonary adenocarcinoma based on chest CT radiomic features.

Yu Y, Yang T, Ma P, Zeng Y, Dai Y, Fu Y Insights Imaging. 2025; 16(1):28.

PMID: 39881024 PMC: 11780022. DOI: 10.1186/s13244-025-01906-w.


Discrepancies in PD-L1 expression, lymphocyte infiltration, and tumor mutational burden in non-small cell lung cancer and matched brain metastases.

Zhang Y, Cheng R, Ding T, Wu J Transl Lung Cancer Res. 2025; 13(12):3590-3602.

PMID: 39830744 PMC: 11736585. DOI: 10.21037/tlcr-24-735.


Exploring the impact of tertiary lymphoid structures maturity in NSCLC: insights from TLS scoring.

Berthe J, Poudel P, Segerer F, Jennings E, Ng F, Surace M Front Immunol. 2024; 15:1422206.

PMID: 39376565 PMC: 11457083. DOI: 10.3389/fimmu.2024.1422206.


Clinicopathological and prognostic value of tertiary lymphoid structures in lung cancer: a meta-analysis.

Ma L, Qin X, Yu A, Liu H, Pan D, Gao Y Clin Transl Oncol. 2024; .

PMID: 39212910 DOI: 10.1007/s12094-024-03677-0.


References
1.
Feng H, Yang F, Qiao L, Zhou K, Wang J, Zhang J . Prognostic Significance of Gene Signature of Tertiary Lymphoid Structures in Patients With Lung Adenocarcinoma. Front Oncol. 2021; 11:693234. PMC: 8352557. DOI: 10.3389/fonc.2021.693234. View

2.
Li Q, Zhang D, He W, Chen T, Yan Z, Gao X . CD8 T cells located in tertiary lymphoid structures are associated with improved prognosis in patients with gastric cancer. Oncol Lett. 2020; 20(3):2655-2664. PMC: 7400769. DOI: 10.3892/ol.2020.11828. View

3.
Helmink B, Reddy S, Gao J, Zhang S, Basar R, Thakur R . B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020; 577(7791):549-555. PMC: 8762581. DOI: 10.1038/s41586-019-1922-8. View

4.
Dieu-Nosjean M, Goc J, Giraldo N, Sautes-Fridman C, Fridman W . Tertiary lymphoid structures in cancer and beyond. Trends Immunol. 2014; 35(11):571-80. DOI: 10.1016/j.it.2014.09.006. View

5.
Ren F, Xie M, Gao J, Wu C, Xu Y, Zang X . Tertiary lymphoid structures in lung adenocarcinoma: characteristics and related factors. Cancer Med. 2022; 11(15):2969-2977. PMC: 9359870. DOI: 10.1002/cam4.4796. View